1.Oral report by Dr.Yanzhi Song"allo-HSCT improves survival outcomes in R/R B-ALL patients who are not in remission or MRD-positive after CAR-T treatment"

2.Oral Report by Head Nurse Wang Xiaoxia on the Application of Multimedia Digital Platform to Carry out HSCT Pre-patient Education under the COVID-19 Epidemic

3.Dr.Zhao Wing-keung presents the poster"Secondary allo-HSCT for Intensity Reduction pretreatment and Donor Replacement".

4.Dr.Li Zhihui shows the poster"The good effect of allo-HSCT in the treatment of MLL gene-related hematological malignancies".

5.Dr.Hui Shi presents the poster"Relapsed T-ALL after allo-HSCT treatment with Donor-derived CD7 CAR-T:Phase I Trial".

6.Dr.Wang Rui shows the poster"allo-HSCT Improves Poor prognosis in MLL-AF6-positive AML patients".

7.Dr.Zhanxiang Liu presents the poster"CAR-T bridging allo-HSCT achieves good results in the treatment of R/R Ph+B-ALL patients".

8.Head Nurse Wang Xiaoxia showed the wall report"Nursing of a patient with AML complicated with sepsis and pleural effusion receiving CD33 CAR-T bridge for the second HSCT treatment".